◆英語タイトル：Crescita Therapeutics Inc (CTX) - Financial and Strategic SWOT Analysis Review
◆レポート形式：英語 / PDF
Crescita Therapeutics Inc (Crescita Therapeutics) is a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company’s products comprise Pliaglis, Alyria, Laboratoire Dr Renaud, Pro-Derm, Premiology and ISDIN. Its Pliaglis is a local anesthetic cream for superficial dermatological and cosmetic procedures. Crescita Therapeutics develops Mical used in therapeutic areas of psoriasis and dermatological skin treatment. The company develops products using drug delivery platforms which include multiplexed molecular penetration enhancers and DuraPeel. It markets products in the US, Canada and Mexico. Crescita Therapeutics is headquartered in Laval, Ontario, Canada.
Crescita Therapeutics Inc Key Recent Developments
Feb 04,2019: Crescita Therapeutics Inc. and Tetra Natural Health Collaborate to Enhance Transdermal Delivery of Beta-Caryophyllene in Tetra s Dermatology Product Portfolio
Oct 15,2018: Crescita’s patented delivery technologies demonstrate enhanced skin permeation of cannabidiol
Aug 10,2018: Crescita Therapeutics reports 2018 second quarter results
May 09,2018: Crescita Therapeutics Reports 2018 First Quarter Results
Apr 26,2018: Crescita Therapeutics To Present at the 2018 Bloom Burton &Co. Healthcare Investor Conference in Toronto
This comprehensive SWOT profile of Crescita Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Crescita Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Crescita Therapeutics Inc – Key Information
Crescita Therapeutics Inc – Overview
Crescita Therapeutics Inc – Key Employees
Crescita Therapeutics Inc – Key Employee Biographies
Crescita Therapeutics Inc – Key Operational Heads
Crescita Therapeutics Inc – Major Products and Services
Crescita Therapeutics Inc – History
Crescita Therapeutics Inc – Company Statement
Crescita Therapeutics Inc – Locations And Subsidiaries
Crescita Therapeutics Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Crescita Therapeutics Inc – Business Description
Crescita Therapeutics Inc – Corporate Strategy
Crescita Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Crescita Therapeutics Inc – Strengths
Crescita Therapeutics Inc – Weaknesses
Crescita Therapeutics Inc – Opportunities
Crescita Therapeutics Inc – Threats
Crescita Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Crescita Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Crescita Therapeutics Inc, Key Information
Crescita Therapeutics Inc, Key Ratios
Crescita Therapeutics Inc, Share Data
Crescita Therapeutics Inc, Major Products and Services
Crescita Therapeutics Inc, History
Crescita Therapeutics Inc, Key Employees
Crescita Therapeutics Inc, Key Employee Biographies
Crescita Therapeutics Inc, Key Operational Heads
Crescita Therapeutics Inc, Other Locations
Crescita Therapeutics Inc, Subsidiaries
Crescita Therapeutics Inc, Key Manufacturing facilities
Crescita Therapeutics Inc, Key Competitors
Crescita Therapeutics Inc, SWOT Analysis
Crescita Therapeutics Inc, Ratios based on current share price
Crescita Therapeutics Inc, Annual Ratios
Crescita Therapeutics Inc, Interim Ratios
Capital Market Ratios
List of Figures
Crescita Therapeutics Inc, Performance Chart
Crescita Therapeutics Inc, Ratio Charts
Crescita Therapeutics Inc (CTX)：企業の財務・戦略的SWOT分析(Crescita Therapeutics Inc (CTX) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。